1,877 cancer cases detected in Tiruchy in last 4 years
TIRUCHY: A total of 1,877 people were diagnosed with cancer, including 811 with breast cancer, 650 cervical cancer, and 416 with oral cancers, through the Makkalai Thedi Maruthuvam doorstep health scheme in Tiruchy in the last four years and referred to government hospitals for treatment .
Extending the programme, health minister M Subramaniam on Monday inaugurated state-wide Organised Cancer Screening (OCS) camps at Tiruvallur and 12 other districts. In Tiruchy, collector M Pradeep Kumar inaugurated the camp at a wellness centre in Woraiyur.
This is part of Tamil Nadu's Rs 27-crore cancer control strategy, and the drive focuses on detecting oral, breast, and cervical cancer. Explaining details, officials said, of Tiruchy's total population of 29,29,523, 22.20 lakh adults will be screened for oral cancer, while 7.67 lakh women will be tested for breast and cervical cancer.
The targets are based on population surveys. 'Early detection saved lives in the past four years, but we've only seen the tip of the iceberg. Now, we aim to cover the entire vulnerable population,' said Dr V Thilagendran, District Programme Officer for Non-Communicable Diseases.
Adults over 18 will be screened annually for oral cancer, while women above 30 will undergo tests every three years for breast and cervical cancer. Suspected cases will be referred to government hospitals, medical colleges, and private facilities under the Chief Minister's health insurance scheme.
Screenings are available at 25 urban and 142 rural wellness centres, and 84 primary health centres,in Tiruchy. Under this scheme, women health volunteers (WHVs) will personally invite people for free checks at nearby centres. Screening camps are also planned at government offices and workplaces to ensure broad coverage.
Despite health workers delivering door-to-door invitations in pilot districts, many people did not attend the screenings, officials said. 'Early detection is possible only if people come for screening. We urge every eligible person to make use of this opportunity it could save their life,' said Dr T S Selvavinayagam, Director of Public Health.
Industries Minister T R B Rajaa inaugurated the screening camp at Mannargudi in Tiruvarur district. A total of 1,72,729 women aged 30 years and above are expected to be screened for cervical cancer, breast cancer and oral cancer. Moreover 4,71,200 men and women aged above 18 years will be screened for oral cancer. District Collector V Mohanachandran was present on the occasion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
36 minutes ago
- NDTV
US Man Weighing 151 Kg Sues Disney For Rs 42 Lakh After Waterslide Injury
A US man has sued Walt Disney for Rs 42.7 lakh ($50,000) in damages after he suffered injuries on a waterslide at the entertainment behemoth's amusement park. Eugene Strickland, who weighed 151 kg at the time, 13 kg above the ride's weight limit -- was on the Downhill Double Dipper at Disney's Blizzard Beach Waterpark in July 2021 when the incident took place. As per the lawsuit filed last week, Mr Strickland has blamed the waterslide's design and "exhilarating speeds" for causing the injuries. It allegedly caused his inner tube to dislodge from beneath him and made him "land with force onto the hard plastic surface of the slide". He said he "suffered serious bodily injury" which resulted in pain and suffering, disability, scarring, disfigurement, mental anguish and loss of capacity for the enjoyment of life. The Florida resident argued that Walt Disney World displayed negligence and failed to maintain safe premises. He also claims that the theme park was aware of the "safety hazard" and "concealed trap" that led to his injuries. "Our client was severely injured on a ride at Disney's Blizzard Beach. He has filed a lawsuit alleging that it was the defendant's lax safety measures and oversight that contributed to those injuries. We are pursuing justice for him and working to hold Disney accountable for their alleged negligence," his attorneys told People. It remains unclear in the complaint if Mr Strickland was aware of the weight limit before entering the slide. This is not the first instance when Walt Disney World has been sued. Last year, Jeffrey Piccolo filed a "wrongful death" lawsuit against Disney after his wife, Kanokporn Tangsuan, died when she suffered an allergic reaction from her meal at a restaurant at the Walt Disney World Resort in Florida. However, Disney said Mr Piccolo signed away his right to take action against the company when he agreed to the terms and conditions of Disney+ during a free trial of the streaming service several years ago.
Hans India
44 minutes ago
- Hans India
Kishan touts ESI Med College as the best hospital in country
Hyderabad: Union Minister Kishan Reddy visited the ESIC Hospital in Sanathnagar on Monday, where he reviewed the current conditions of the hospital across all departments. During his visit, hospital staff presented an overview of the new policies and medical services being provided to working families and patients through a screen presentation. Later, he inspected the construction work of the newly built building. Earlier in the day, he planted a sapling on the hospital premises. Addressing the media after the review, Kishan Reddy congratulated the hospital management and staff for receiving the award for being the best hospital in the country, recognising the achievements of the Sanath Nagar ESI Medical College and Hospital. He congratulated the hospital management and staff for their efforts. He said the hospital caters to approximately 3,000 outpatients daily, with around 900 patients visiting the super speciality hospital. The ESI Hospital is becoming a strong competitor to corporate hospitals, and there is a commitment to enhance its specialisation in various medical fields soon, including a focus on organ transplants. Telangana has registered 1.7 million ESI cards, allowing access to medical services for approximately 8 million people. Steps are being taken to facilitate online doctor appointments, in-home blood sampling, and mobile delivery of test results. A record 2,900 patients are currently visiting the outpatient department (OP). 'The Modi government is significantly boosting healthcare in Telangana; the Center has approved AIIMS, ESI, and two new medical colleges, which are already underway. A new medical college is under construction with an investment of Rs 800 crore, with 300 beds. It is set to open soon, alongside improvements in infrastructure using the latest technology. Thirty-five per cent of seats in the medical college have been reserved for Insured Persons (IP), with 1,027 students currently enrolled in the MBBS program. Over 3,000 MBBS graduates have already completed their studies. They are serving the community, while 44 students have completed MD and MS degrees and are providing medical services. Each year, 307 students graduate from various departments, with prestigious specialization courses available at the ESI Hospital and Medical College, he added. The institution offers Medical, Paramedical, MD, MS, MCh, and DNB programs education courses.
Business Standard
an hour ago
- Business Standard
Biocon gets CDSCO approval for Liraglutide drug substance
Biocon said that it has received an approval from the Drugs Controller General of India (DCGI), under the central drugs standard control organisation (CDSCO), for its Liraglutide drug substance. Additionally, its wholly owned subsidiary, Biocon Pharma, has received CDSCO approval for the Liraglutide drug product (6 mg/ml solution for injection in pre-filled pen and cartridge). The said approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled type 2 diabetes mellitus in adults, adolescents and children aged 10 years and above, as an adjunct to diet and exercise. The approval was received from the CDSCO under the recently formulated 101 route that enables recognition of approvals granted by established and referenced serious regulatory authorities. Siddharth Mittal, chief executive officer and managing director, Biocon, said: The approval of our first vertically integrated GLP-1 in India, Liraglutide, is another significant step forward in expanding access of this product to patients suffering from diabetes. India has one of the highest number of people with diabetes globally, with estimates exceeding 77 million cases, and expected to rise further. The approval enables us to address a critical need by making this drug available, and aligns with Biocons mission to provide affordable, lifesaving medications to those who need it the most. We are now gearing up to launch the product expeditiously through our commercialization partners in India. Biocon is an innovation-led global biopharmaceutical company focused on improving affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune diseases. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets, as well as generic formulations in the U.S. and Europe The companys consolidated net profit surged 154.2% to Rs 344.50 crore on 12.8% jump in net sales to Rs 4,358.10 crore in Q4 FY25 over Q4 FY24. The counter shed 0.45% to end at Rs 334.05 on the BSE.
